Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.
You can purchase shares of Achilles Therapeutics (NASDAQ:ACHL) through any online brokerage.
Other companies in Achilles Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS) and CARISMA Therapeutics (NASDAQ:CARM).
Achilles Therapeutics has a consensus price target of $2.83.
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $0.992 last updated October 22, 2024 at 3:51 PM EDT.
There are no upcoming dividends for Achilles Therapeutics.
Achilles Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Achilles Therapeutics.
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.